Shuttle Pharmaceuticals (NASDAQ:SHPH) Trading Down 16.7% – Here’s Why

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH)’s stock price was down 16.7% on Monday . The stock traded as low as $0.30 and last traded at $0.31. Approximately 1,723,207 shares changed hands during mid-day trading, an increase of 215% from the average daily volume of 546,832 shares. The stock had previously closed at $0.37.

Shuttle Pharmaceuticals Stock Performance

The stock has a market cap of $1.91 million, a P/E ratio of -0.07 and a beta of -1.04. The stock has a 50-day moving average price of $0.50 and a 200-day moving average price of $0.82.

About Shuttle Pharmaceuticals

Shuttle Pharmaceuticals Holdings, Inc, a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers .